Bioresponsive antisense DNA gold nanobeacons as a hybrid in vivo theranostics platform for the inhibition of cancer cells and metastasis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Bao, Chenchen ^a   Conde, João ^b,c   Curtin, James ^d   Artzi, Natalie ^b,e   Tian, Furong ^d   Cui, Daxiang ^a  

^a Shanghai Jiao Tong University   (China)

^b HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GOLD; METAL NANOPARTICLE; PROTEIN P21;

ANIMAL; CHEMISTRY; DISEASE MODEL; DRUG SCREENING; GENETICS; HUMAN; INFRARED SPECTROSCOPY; MORTALITY; MOUSE; NEOPLASMS; NUDE MOUSE; THERANOSTIC NANOMEDICINE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DNA, ANTISENSE; GOLD; HUMANS; METAL NANOPARTICLES; MICE; MICE, NUDE; NEOPLASMS; PROTO-ONCOGENE PROTEINS P21(RAS); SPECTROSCOPY, FOURIER TRANSFORM INFRARED; THERANOSTIC NANOMEDICINE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84937718141     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12297     Document Type: Article

References (53)

1. Tyagi, S. & Kramer, F. R. Molecular beacons: probes that fluoresce upon hybridization. Nat. Biotechnol. 14, 303-308 (1996).
2. Tsourkas, A., Behlke, M. A., Rose, S. D. & Bao, G. Hybridization kinetics and thermodynamics of molecular beacons. Nucleic Acids Res. 31, 1319-1330 (2003).
3. Conde, J., Bao, C., Cui, D., Baptista, P. V. & Tian, F. Antibody-drug gold nanoantennas with Raman spectroscopic fingerprints for in vivo tumour theranostics. J. Control Release 183, 87-93 (2014).
4. Conde, J., Doria, G. & Baptista, P. Noble metal nanoparticles applications in cancer. J. Drug Deliv. 2012, 751075 (2012).
5. Peer, D. et al. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751-760 (2007).
6. Palonpon, A. F. et al. Raman and SERS microscopy for molecular imaging of live cells. Nat. Protoc. 8, 677-692 (2013).
7. Conde, J. et al. RNAi-based glyconanoparticles trigger apoptotic pathways for in vitro and in vivo enhanced cancer-cell killing. Nanoscale 7, 9083-9091 (2015).
8. Kumar, S., Aaron, J. & Sokolov, K. Directional conjugation of antibodies to nanoparticles for synthesis of multiplexed optical contrast agents with both delivery and targeting moieties. Nat. Protoc. 3, 314-320 (2008).
9. Shu, Y., Shu, D., Haque, F. & Guo, P. Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells. Nat. Protoc. 8, 1635-1659 (2013).
10. Conde, J., De La Fuente, J. M. & Baptista, P. V. RNA quantification using gold nanoprobes - application to cancer diagnostics. J. Nanobiotechnology. 8, 5 (2010).
11. Zhang, J., Song, S., Wang, L., Pan, D. & Fan, C. A. gold nanoparticle-based chronocoulometric DNA sensor for amplified detection of DNA. Nat. Protoc. 2, 2888-2895 (2007).
12. Liu, J. & Lu, Y. Preparation of aptamer-linked gold nanoparticle purple aggregates for colorimetric sensing of analytes. Nat. Protoc. 1, 246-252 (2006).
13. Cao, Y. C., Jin, R., Thaxton, C. S. & Mirkin, C. A. A two-color-change, nanoparticle-based method for DNA detection. Talanta 67, 449-455 (2005).
14. Rosa, J. P., Lima, J. C. & Baptista, P. V. Experimental photophysical characterization of fluorophores in the vicinity of gold nanoparticles. Nanotechnology. 22, 415202 (2011).
15. Anger, P., Bharadwaj, P. & Novotny, L. Enhancement and quenching of single-molecule fluorescence. Phys. Rev. Lett. 96, 113002 (2006).
16. Conde, J., De La Fuente, J. M., & Baptista, P. V. In vitro transcription and translation inhibition via DNA functionalized gold nanoparticles. Nanotechnology. 21, 505101 (2010).
17. Rosi, N. L. et al. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 312, 1027-1030 (2006).
18. Conde, J. et al. In vivo tumor targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models. Biomaterials 34, 7744-7753 (2013).
19. Conde, J. et al. Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing. ACS Nano. 6, 8316-8324 (2012).
20. Patel, P. C., Giljohann, D. A., Seferos, D. S. & Mirkin, C. A. Peptide antisense nanoparticles. Proc. Natl. Acad. Sci. USA 105, 17222-17226 (2008).
21. Modarresi, F. et al. Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation. Nat. Biotechnol. 30, 453-459 (2012).
22. Fichou, Y. & Ferec, C. The potential of oligonucleotides for therapeutic applications. Trends Biotechnol. 24, 563-570 (2006).
23. Agrawal, S. Antisense oligonucleotides: towards clinical trials. Trends Biotechnol. 14, 376-387 (1996).
24. Tamm, I., Dorken, B. & Hartmann, G. Antisense therapy in oncology: new hope for an old idea? Lancet 358, 489-497 (2001).
25. Jing, J. J. et al. Gastric cancer incidence and mortality in Zhuanghe, China, between 2005 and 2010. World J. Gastroenterol. 18, 1262-1269 (2012).
26. Meireles, S. I. et al. Molecular classifiers for gastric cancer and nonmalignant diseases of the gastric mucosa. Cancer Res. 64, 1255-1265 (2004).
27. Hechtman, J. F. et al. Novel oncogene and tumor suppressor mutations in KIT and PDGFRA wild type gastrointestinal stromal tumors revealed by next generation sequencing. Genes Chromosomes Cancer 54, 177-184 (2015).
28. Qian, Z. et al. Whole genome gene copy number profiling of gastric cancer identifies PAK1 and KRAS gene amplification as therapy targets. Genes Chromosomes Cancer 53, 883-894 (2014).
29. Kranenburg, O. The KRAS oncogene: Past, present, and future. Biochim. Biophys. Acta. 1756, 81-82 (2005).
30. Arrington, A. K. et al. Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer. Int. J. Mol. Sci. 13, 12153-12168 (2012).
31. Rosa, J., Conde, J., De La Fuente, J. M., Lima, J. C., & Baptista, P.V. Gold-nanobeacons for real-time monitoring of RNA synthesis. Biosens. Bioelectron. 36, 161-167 (2012).
32. Conde, J., Rosa, J., De La Fuente, J. M. & Baptista, P. V. Gold-nanobeacons for simultaneous gene specific silencing and intracellular tracking of the silencing events. Biomaterials 34, 2516-2523 (2013).
33. Conde, J. et al. Gold-nanobeacons for gene therapy: evaluation of genotoxicity, cell toxicity and proteome profiling analysis. Nanotoxicology 8, 521-532 (2013).
34. Griffin, J. et al. Size- and Distance-Dependent Nanoparticle Surface-Energy Transfer (NSET) Method for Selective Sensing of Hepatitis C Virus RNA. Chemistry 15, 342-351 (2009).
35. Shi, J. et al. OB glue paste technique for establishing nude mouse human gastric cancer orthotopic transplantation models. World J. Gastroenterol. 14, 4800-4804 (2008).
36. Conde, J., Oliva, N. & Artzi, N. Implantable hydrogel embedded dark-gold nanoswitch as a theranostic probe to sense and overcome cancer multidrug resistance. Proc. Natl. Acad. Sci. USA 112, 1278-1287 (2015).
37. Lee, H. C. et al. Metastasis of gastric carcinoma to the thyroid and lung: a case report and review of literature. J. Zhejiang Univ. Sci. B. 11, 542-546 (2010).
38. Bassan, P. et al. Resonant Mie scattering in infrared spectroscopy of biological materials-understanding the 'dispersion artefact'. Analyst 134, 1586-1593 (2009).
39. Banyay, M., Sarkar, M. & Graslund, A. A library of IR bands of nucleic acids in solution. Biophys. Chem. 104, 477-488 (2003).
40. Agarwal, S., Jangir, D. K., Singh, P. & Mehrotra, R. Spectroscopic analysis of the interaction of lomustine with calf thymus DNA. J. Photochem. Photobiol. B. 130, 281-286 (2014).
41. Tyagi, G., Pradhan, S., Srivastava, T. & Mehrotra, R. Nucleic acid binding properties of allicin: Spectroscopic analysis and estimation of anti-tumor potential. Biochim. Biophys. Acta. 1840, 350-356 (2014).
42. Jangir, D. K., Kundu, S. & Mehrotra, R. Role of Minor Groove Width and Hydration Pattern on Amsacrine Interaction with DNA. Plos One 8, (2013).
43. Alex, S. & Dupuis, P. Ft-Ir and Raman Investigation of Cadmium Binding by DNA. Inorganica Chim. Acta. 157, 271-281 (1989).
44. De Jong, W. H. et al. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29, 1912-1919 (2008).
45. Al-Mehdi, A. B. et al. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat. Med. 6, 100-102 (2000).
46. Podsypanina, K. et al. Seeding and propagation of untransformed mouse mammary cells in the lung. Science 321, 1841-1844 (2008).
47. Kong, J. H. et al. Lung metastases in metastatic gastric cancer: pattern of lung metastases and clinical outcome. Gastric Cancer 15, 292-298 (2012).
48. Duda, D. G. et al. Malignant cells facilitate lung metastasis by bringing their own soil. Proc. Natl. Acad. Sci. USA 107, 21677-21682 (2010).
49. Dauphin, M. et al. Vimentin expression predicts the occurrence of metastases in non small cell lung carcinomas. Lung Cancer 81, 117-122 (2013).
50. He, X. P. et al. The relationship between KRAS gene mutations and HLA class I antigen downregulation in the metastasis of non-small cell lung cancer. J. Int. Med. Res. 41, 1473-1483 (2013).
51. Lee, P. C. & Meisel, D. Adsorption and surface-enhanced Raman of dyes on silver and gold sols. J. Phys. Chem. 86 (17), 3391-3395 (1982).
52. Sanz, V. et al. Effect of PEG biofunctional spacers and TAT peptide on dsRNA loading on gold nanoparticles. J. Nanop. Res. 14, (2012).
53. Conde, J., Rosa, J., De La Fuente, J. M. & Baptista, P. V. Gold-nanobeacons for simultaneous gene specific silencing and intracellular tracking of the silencing events. Biomaterials 34, 2516-2523 (2013).